Asgard Therapeutics
Announced 09 Oct 2026$33.8M ยท Series A ยท Technology, Information and Media ยท Sweden
Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy.
โWe're excited to welcome @Asgard Therapeutics to BIO-Europe! Join @Cristiana Pires as she presents on behalf of this pioneering biotech company. Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy.โ
1 more source tracked. Read the full press release and reporter coverage.
Sign up to read โ